FDA Date: 10/22/17
Vigabatrin REMS
Goal of the Vigabatrin REMS Program
The goal of the Vigabatrin REMS Program is to mitigate the risk of vision loss associated with vigabatrin by:
• Ensuring that healthcare providers are educated about the risk of vision loss, the need to counsel patients about the risk, and the need for periodic visual monitoring.
• Ensuring that vigabatrin is only dispensed to patients with documentation that patients are informed about the risk of vision loss associated with vigabatrin and the need for periodic visual monitoring.
• Elements to Assure Safe Use
• Implementation System